Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
Novartis spent 44 percent more on lobbying last quarter than in 2023, surging into the top 10 health lobbying spenders for the first time in years.
- Simplified Text
-
Novartis spent 44 percent more on lobbying last quarter than in 2023
- Confidence Score
- 0.900
- Claim Maker
- Megan R. Wilson
- Context Type
- News Article
- Context Details
-
{ "date": "2024-04-24", "topic": "Pharmaceutical Lobbying", "company": "Novartis", "comparison_period": "2023", "growth_percentage": "44%" } - Subject Tags
- UUID
- 9fdb00fc-9eaa-4cb8-b4cc-fab236d38186
- Vector Index
- ✗ No vector
- Created
- September 11, 2025 at 10:27 PM (1 day ago)
- Last Updated
- September 11, 2025 at 10:27 PM (1 day ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
51
claims
🔥
1 day ago
https://www.politico.com/newsletters/politico-pulse/2024/04/24/pharma-lobbying-up-in-2024-00153996
Pharmaceutical industry lobbying spending surged in Q1 2024. Increased spending focuses on PBM reform and other congressional issues. This follows recent government funding bill negotiations.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.